Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tissue concentrations of clofazimine (B663) in man.

Literature DB >> 4429181

Tissue concentrations of clofazimine (B663) in man.

R E Mansfield.

Abstract

Entities: Chemical Species

Mesh：

Substances：
Clofazimine

Year: 1974 PMID： 4429181 DOI： 10.4269/ajtmh.1974.23.1116

Source DB: PubMed Journal: Am J Trop Med Hyg ISSN： 0002-9637 Impact factor: 2.345

Keyword Cloud
Cited

× No keyword cloud information.

22 in total

1. Phagocytosed Clofazimine Biocrystals Can Modulate Innate Immune Signaling by Inhibiting TNFα and Boosting IL-1RA Secretion.

Authors: Gi S Yoon; Sudha Sud; Rahul K Keswani; Jason Baik; Theodore J Standiford; Kathleen A Stringer; Gus R Rosania
Journal: Mol Pharm Date: 2015-06-05 Impact factor: 4.939

2. Prooxidative activities of 10 phenazine derivatives relative to that of clofazimine.

Authors: B M Zeis; R Anderson; J F O'Sullivan
Journal: Antimicrob Agents Chemother Date: 1987-05 Impact factor: 5.191

3. Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis.

Authors: Sandeep Tyagi; Nicole C Ammerman; Si-Yang Li; John Adamson; Paul J Converse; Rosemary V Swanson; Deepak V Almeida; Jacques H Grosset
Journal: Proc Natl Acad Sci U S A Date: 2015-01-05 Impact factor: 11.205

4. Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy.

Authors: Rosemary V Swanson; Nicole C Ammerman; Bongani Ngcobo; John Adamson; Chivonne Moodley; Afton Dorasamy; Sashen Moodley; Zinhle Mgaga; Linda A Bester; Sanil D Singh; Deepak V Almeida; Jacques H Grosset
Journal: Antimicrob Agents Chemother Date: 2016-04-22 Impact factor: 5.191

5. Pharmacokinetics and pharmacodynamics of clofazimine in a mouse model of tuberculosis.

Authors: Rosemary V Swanson; John Adamson; Chivonne Moodley; Bongani Ngcobo; Nicole C Ammerman; Afton Dorasamy; Sashen Moodley; Zinhle Mgaga; Asa Tapley; Linda A Bester; Sanil Singh; Jacques H Grosset; Deepak V Almeida
Journal: Antimicrob Agents Chemother Date: 2015-03-09 Impact factor: 5.191

Tissue concentrations of clofazimine (B663) in man.

1. Phagocytosed Clofazimine Biocrystals Can Modulate Innate Immune Signaling by Inhibiting TNFα and Boosting IL-1RA Secretion.

2. Prooxidative activities of 10 phenazine derivatives relative to that of clofazimine.

3. Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis.

4. Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy.

5. Pharmacokinetics and pharmacodynamics of clofazimine in a mouse model of tuberculosis.

6. In Vitro Susceptibility of Nocardia farcinica to the Antimycobacterial Drug Clofazimine.

7. Macrophage-Mediated Clofazimine Sequestration Is Accompanied by a Shift in Host Energy Metabolism.

8. Clofazimine Reduces the Survival of Salmonella enterica in Macrophages and Mice.

9. Assessment of clofazimine activity in a second-line regimen for tuberculosis in mice.

Review 10. Clinical pharmacokinetic considerations in the treatment of patients with leprosy.